FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Par Pharmaceutical Glycopyrrolate Tablets Recall

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist

Par Pharmaceutical Inc. · Chestnut Ridge, NY

Risk level
Class II
Reported by FDA
Apr 8, 2020
Recall ID
D-1071-2020
Check your lot numberHow we source this data

Summary

Par Pharmaceutical recalled Glycopyrrolate Tablets starting Mar 30, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1071-2020 on Apr 8, 2020. Reason: Failed Impurities/Degradation Specification: Presence of unknown impurity observed. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specification: Presence of unknown impurity observed.

Product description

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01

Lot numbers, UPCs & expiration codes

Lot # 32809101, Exp 3/2021

Where it was sold

Product was distributed within the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1071-2020
Classification
Class II
Status
Terminated
Recall initiated
Mar 30, 2020
FDA report date
Apr 8, 2020
Quantity
29,352 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Par Pharmaceutical Inc.

Original FDA data

Every field from FDA enforcement report D-1071-2020, exactly as published.

Show all FDA fields
City
Chestnut Ridge
State
NY
Status
Terminated
Country
United States
Event ID
85333
Address
1 Ram Ridge Rd
Code information
Lot # 32809101, Exp 3/2021
Postal code
10977-6714
Report date
Apr 8, 2020
Product type
Drugs
Recall number
D-1071-2020
Classification
Class II
Recalling firm
Par Pharmaceutical Inc.
Product quantity
29,352 bottles
Termination date
Nov 2, 2021
Reason for recall
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01
Distribution pattern
Product was distributed within the United States.
Recall initiation date
Mar 30, 2020
Initial firm notification
Letter
Center classification date
Mar 30, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1071-2020, published Apr 8, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls